Mark Clements, M.D., Ph.D. Chief Medical and Strategy Officer, Glooko
As healthcare providers, we find ourselves at an exciting crossroads in diabetes management. Rapid advancements in technology—from remote patient monitoring to artificial intelligence—have fundamentally altered…
Continue Reading
What You Should Know:
– Fruit Street Health announced that it has received a letter from the Securities and Exchange Commission (“SEC”) confirming the conclusion of the SEC’s investigation into the company. The letter states…
Continue Reading
Three diabetes apps have been made available across Wales to complement a government face-to-face programme that has helped more than 10,000 people.
NHS Wales has invested in a Wales-wide license for the apps that…
What You Should Know:
– Tandem Diabetes Care, an insulin delivery and diabetes technology company, today announced that its Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s…
Continue Reading
Background: The number of older patients with type 2 diabetes has been on the rise, and effective self-management is key to controlling disease progression and its complications. Objective: A home telemedicine intervention combining telemedicine…
Continue Reading
What You Should Know:
– Medtronic announced that its planned New Diabetes Company will be named MiniMed. The name honors the company’s roots, reflecting its original name prior to its acquisition by Medtronic in 2001…
Continue Reading
Chun Yong, CEO at Reach7 Diabetes Studios
Today’s landscape of diabetes care is fraught with challenges: it’s a condition that’s often misunderstood by both patients and the healthcare system, highly prevalent, financially burdensome and frequently…
Continue Reading
What You Should Know:
– LifeMD, Inc., a provider of virtual primary care services announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide).
– The comprehensive package includes both the GLP-1 medication…
Continue Reading
What You Should Know:
– Sequel Med Tech, a company developing state-of-the-art insulin delivery technologies, announced a commercial development agreement with Abbott.
– The collaboration aims for the future integration of Sequel’s twiist™ Automated Insulin Delivery…
Continue Reading
What You Should Know:
– Medtronic today announced its strategic decision to separate its Diabetes business into a new, independent, publicly traded company (“New Diabetes Company”).
– The move aims to create a more focused Medtronic,…
Continue Reading
